All reports
All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports
- 2005 (1) Apply 2005 filter
- 2006 (4) Apply 2006 filter
- 2007 (2) Apply 2007 filter
- 2008 (2) Apply 2008 filter
- 2009 (3) Apply 2009 filter
- 2010 (1) Apply 2010 filter
- 2011 (2) Apply 2011 filter
- 2012 (1) Apply 2012 filter
- 2013 (4) Apply 2013 filter
- 2014 (1) Apply 2014 filter
- 2015 (7) Apply 2015 filter
- 2016 (2) Apply 2016 filter
- 2018 (1) Apply 2018 filter
- Biological and genetic diagnostic tests (7) Apply Biological and genetic diagnostic tests filter
- Cancer (9) Apply Cancer filter
- Digestive System Diseases (1) Apply Digestive System Diseases filter
- Drugs (10) Apply Drugs filter
- Endocrine diseases, diabetes and liver diseases (3) Apply Endocrine diseases, diabetes and liver diseases filter
- Geriatrics and chronic diseases (1) Apply Geriatrics and chronic diseases filter
- Gynaecology, pregnancy and delivery (3) Apply Gynaecology, pregnancy and delivery filter
- Infectious diseases (5) Apply Infectious diseases filter
- Medical imaging (5) Apply Medical imaging filter
- Neurology and brain disease (2) Apply Neurology and brain disease filter
- Pediatrics (1) Apply Pediatrics filter
- Prevention, Screening and vaccination (5) Apply Prevention, Screening and vaccination filter
- Respiratory diseases (1) Apply Respiratory diseases filter
-
MammaPrint® test for personalised management of adjuvant chemotherapy decisions in early breast cancer
KCE Report 298 (2018) Breast cancer is the most commonly diagnosed cancer in women in Belgium and throughout the world. Provided this cancer is in the early stage, treatment is essentially locoregional, that is, via surgery alone or combined with radiation therapy. In theory, this treatment is enough to eradicate the tumour since it is still limited. However, it is known that about 30% of patients treated in this way are at risk of developing remote metastases, because metastatic cancerous cells are already present but undetectable at the time of diagnosis.
-
Economic evaluation of novel direct acting antiviral (DAA) treatment strategies for chronic hepatitis C
KCE Reports 276 (2016)
-
Future scenarios about drug development and drug pricing
KCE Reports 271 (2016)
-
Towards a better managed off-label use of drugs
KCE Reports 252 (2015)
-
Towards a guided and phased introduction of high-risk medical devices in Belgium
KCE Reports 249 (2015)
-
Publicly funded Practice-oriented Clinical Trials
KCE Reports 246 (2015)
-
Oncogenetic testing, diagnosis and follow-up in Birt-Hogg-Dubé syndrome, familial atypical multiple mole melanoma syndrome and neurofibromatosis 1 and 2
KCE Reports 243 (2015)
-
Next generation sequencing gene panels for targeted therapy in oncology and haemato-oncology
KCE Reports 240 (2015)
-
Oncogenetic testing and follow-up for women with familial breast/ovarian cancer, Li Fraumeni syndrome and Cowden syndrome
KCE Reports 236 (2015)
-
Hadron therapy in children – an update of the scientific evidence for 15 paediatric cancers
KCE Reports 235 (2015)
-
The non-invasive prenatal test (NIPT) for trisomy 21 – health economic aspects
KCE Reports 222 (2014)
-
Non-Small Cell and Small Cell Lung Cancer: Diagnosis, Treatment and Follow-up
KCE Reports 206 (2013)
-
Extremity-only MRI
KCE Reports 205 (2013)
-
Barriers and opportunities for the uptake of biosimilar medicines in Belgium
KCE Reports 199 (2013)
-
Innovative radiotherapy techniques: a multicentre time-driven activity-based costing study
KCE Reports 198 (2013)
-
[Hepatitis C: Screening and Prevention]
KCE Reports 173 (2012)
-
[Economic evaluation of antiviral treatment of chronic hepatitis B in Belgium]
KCE Reports 157 (2011)
-
The pre-market clinical evaluation of innovative high-risk medical devices
KCE Reports 158 (2011)
-
Cost-effectiveness of antiviral treatment of chronic hepatitis B in Belgium. Part 1: Literature review and results of a national study
KCE Reports 127 (2010)
-
Pharmaceutical and non-pharmaceutical interventions for Alzheimer’s Disease, a rapid assessment
KCE Reports 111 (2009)